Novavax Inc. Stock Rises Wednesday, Outperforms Market

Kimco Realty Corp

Change company Symbol lookup

Select an option...

KIM Kimco Realty Corp

OEZVF Verbund AG

TRKA Troika Media Group Inc

$NQDMEU3030CADN Nasdaq DM Europe Insurance Net Total

CDAK Codiak BioSciences, Inc.

TXT Textron Inc

INSG Inseego Corp

AVDL Avadel Pharmaceuticals PLC

LCSHY Lancashire Holdings Ltd

NET Cloudflare Inc

Real Estate : Retail REITs | Mid Cap Blend

Company profile

Kimco Realty Corporation, formerly New KRC Corp., is a real estate investment trust (REIT). The Company is an owner and operator of open-air, grocery-anchored shopping centers, including mixed-use assets. The Company's portfolio is primarily concentrated in the first-ring suburbs of metropolitan markets, including those in high-barrier-to-entry coastal markets and Sun Belt cities, with a tenant mix focused on essential, necessity-based goods and services that drive multiple shopping trips per week. It specializes in shopping center ownership, management, acquisitions, and redevelopment activities. It owns interests in about 526 United States shopping centers and mixed-use assets comprising 91 million square feet of gross leasable space. The Company's properties include 2200 Westlake, Camelback Miller Plaza, Grand Parkway Marketplace, Kentlands Market Square, Scottsdale Waterfront, Jericho Commons, Cupertino Village, Centro Arlington, and Westlake Shopping Center, among others.

Novavax Inc. Stock Rises Wednesday, Outperforms Market

5:15 pm ET January 4, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) surged 15.73% to $11.33 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.69% to 10,458.76 and the Dow Jones Industrial Average rising 0.40% to 33,269.77. Novavax Inc. closed $128.27 short of its 52-week high ($139.60), which the company reached on January 5th.

The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 1.09% to $180.13, Pfizer Inc. (PFE) fell 2.20% to $50.13, and Merck & Co. Inc. (MRK) rose 0.85% to $112.08. Trading volume (9.9 M) eclipsed its 50-day average volume of 6.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 4, 2023.

(END) Dow Jones Newswires

January 04, 2023 17:15 ET (22:15 GMT)